Harvard Case - Kevin Sharer at Amgen: Sustaining the High-Growth Company (A)
"Kevin Sharer at Amgen: Sustaining the High-Growth Company (A)" Harvard business case study is written by William W. George, Andrew N. McLean. It deals with the challenges in the field of Organizational Behavior. The case study is 16 page(s) long and it was first published on : Oct 5, 2005
At Fern Fort University, we recommend that Kevin Sharer implement a strategic plan to address Amgen's challenges in sustaining high growth. This plan should focus on diversifying the product portfolio, strengthening the R&D pipeline, embracing a more collaborative and innovative organizational culture, and enhancing leadership development. This strategy will enable Amgen to navigate the changing landscape of the biotechnology industry, maintain its competitive edge, and continue its journey as a leading innovator in the field.
2. Background
Amgen, a leading biotechnology company, faced the challenge of sustaining high growth in the late 1990s. The company's initial success with its blockbuster drug, Epogen, had propelled it to the forefront of the industry. However, the company was heavily reliant on this single product, and its future growth was uncertain. Kevin Sharer, the newly appointed CEO, had the daunting task of navigating Amgen through this critical juncture.
The key protagonists in this case study are:
- Kevin Sharer: The newly appointed CEO of Amgen, tasked with steering the company towards sustained growth.
- Amgen's Board of Directors: Responsible for setting the strategic direction and overseeing the company's performance.
- Amgen's Senior Management Team: Responsible for implementing the company's strategy and managing its operations.
- Amgen's Employees: The backbone of the company, responsible for driving innovation and delivering results.
3. Analysis of the Case Study
The case study highlights several key challenges facing Amgen:
- Product Portfolio Dependence: Amgen's heavy reliance on Epogen made it vulnerable to competition and market shifts.
- R&D Pipeline: The company's R&D pipeline was not robust enough to ensure a steady stream of new products.
- Organizational Culture: Amgen's culture, while successful in its early years, was becoming increasingly rigid and bureaucratic, hindering innovation and collaboration.
- Leadership Development: The company lacked a clear succession plan and a strong leadership development program.
To analyze these challenges, we can employ the SWOT framework:
Strengths:
- Strong brand reputation
- Established research and development capabilities
- Experienced and skilled workforce
- Strong financial position
Weaknesses:
- Product portfolio dependence
- Limited R&D pipeline
- Bureaucratic organizational culture
- Lack of leadership development
Opportunities:
- Growing demand for biotechnology products
- Emerging markets
- Technological advancements
- Partnerships and acquisitions
Threats:
- Competition from established pharmaceutical companies
- Regulatory challenges
- Intellectual property disputes
- Economic downturn
4. Recommendations
To address these challenges and ensure sustained growth, Amgen should implement the following recommendations:
1. Diversify the Product Portfolio:
- Invest in R&D for new products: Amgen should prioritize developing a diverse portfolio of products across various therapeutic areas. This will reduce dependence on Epogen and mitigate risks associated with market fluctuations.
- Strategic acquisitions and partnerships: Explore strategic acquisitions of promising biotech companies with innovative products and technologies. Partnerships with other companies can also provide access to new markets and expertise.
- Expand into new therapeutic areas: Amgen should expand its focus beyond hematology and oncology into areas like immunology, neurology, and cardiovascular diseases.
2. Strengthen the R&D Pipeline:
- Increase R&D investment: Allocate more resources to research and development to accelerate the discovery and development of new drugs.
- Foster a culture of innovation: Encourage creativity and experimentation among researchers. Implement programs that reward innovative ideas and encourage collaboration across departments.
- Leverage technology and analytics: Utilize advanced technologies like artificial intelligence and big data to accelerate drug discovery and development.
3. Embrace a Collaborative and Innovative Organizational Culture:
- Promote cross-functional collaboration: Encourage teams from different departments to work together on projects, fostering a more integrated and innovative approach.
- Empower employees: Delegate decision-making authority to lower levels, encouraging employee ownership and initiative.
- Develop a culture of open communication: Encourage open communication and feedback at all levels of the organization.
4. Enhance Leadership Development:
- Implement a comprehensive leadership development program: Develop a structured program that provides training and mentorship opportunities for high-potential employees.
- Establish a clear succession plan: Identify and groom potential successors for key leadership positions to ensure continuity and smooth transitions.
- Promote diversity and inclusion: Create a diverse and inclusive workplace that attracts and retains top talent from various backgrounds and perspectives.
5. Basis of Recommendations
These recommendations are based on the following considerations:
- Core competencies and consistency with mission: The recommendations align with Amgen's core competencies in research and development, and its mission to deliver innovative therapies that improve patients' lives.
- External customers and internal clients: The recommendations aim to satisfy the needs of external customers by providing them with a wider range of effective therapies, while also empowering internal clients (employees) to contribute their best.
- Competitors: The recommendations are designed to help Amgen stay ahead of its competitors by fostering innovation, diversifying its product portfolio, and building a more agile and responsive organization.
- Attractiveness ' quantitative measures: The recommendations are expected to lead to increased revenue, market share, and profitability for Amgen.
6. Conclusion
By implementing these recommendations, Amgen can overcome its challenges and achieve sustained high growth. By diversifying its product portfolio, strengthening its R&D pipeline, embracing a more collaborative and innovative organizational culture, and enhancing leadership development, Amgen can position itself for continued success in the dynamic biotechnology industry.
7. Discussion
Other alternatives not selected include:
- Focusing solely on cost reduction: This approach could lead to short-term gains but could also stifle innovation and long-term growth.
- Merging with another company: While this could provide access to new markets and technologies, it could also be a risky and complex undertaking.
The key assumptions of our recommendations are:
- The biotechnology industry will continue to grow: This assumption is based on the increasing demand for innovative therapies and the ongoing advancements in biotechnology.
- Amgen can successfully develop and commercialize new products: This assumption is based on Amgen's strong track record in research and development and its ability to bring new products to market.
- Amgen can attract and retain top talent: This assumption is based on Amgen's reputation as a leading biotechnology company and its commitment to creating a positive and rewarding work environment.
8. Next Steps
To implement these recommendations, Amgen should take the following steps:
- Develop a detailed implementation plan: This plan should outline the specific actions, timelines, and resources required to implement each recommendation.
- Communicate the plan to all employees: Open and transparent communication about the strategic plan is essential to gain buy-in and support from employees.
- Monitor progress and make adjustments as needed: Regularly track progress towards the goals outlined in the plan and make adjustments as necessary to ensure success.
By taking these steps, Amgen can successfully navigate the challenges of sustaining high growth and continue its journey as a leading innovator in the biotechnology industry.
Hire an expert to write custom solution for HBR Organizational Behavior case study - Kevin Sharer at Amgen: Sustaining the High-Growth Company (A)
more similar case solutions ...
Case Description
In 2005, Kevin Sharer reflects on the challenges of sustaining the growth and success that have brought Amgen to the position of third-largest U.S. pharmaceuticals company by market capitalization and the challenge of maintaining the higher P/E ratio it traditionally held. Profiles the leadership and development of Sharer, tracing his career from the U.S. Navy through McKinsey and Co., GE, and MCI to his entrance at Amgen as president and COO. Provides information on the history and business of Amgen and its science-based discovery model. Provides information about the protagonist's career, management style, learning style, aspirations, and motivations. Raises questions about leadership in sustaining discovery-driven growth and leadership succession.
🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Write my custom case study solution for Harvard HBR case - Kevin Sharer at Amgen: Sustaining the High-Growth Company (A)
Hire an expert to write custom solution for HBR Organizational Behavior case study - Kevin Sharer at Amgen: Sustaining the High-Growth Company (A)
Kevin Sharer at Amgen: Sustaining the High-Growth Company (A) FAQ
What are the qualifications of the writers handling the "Kevin Sharer at Amgen: Sustaining the High-Growth Company (A)" case study?
Our writers hold advanced degrees in their respective fields, including MBAs and PhDs from top universities. They have extensive experience in writing and analyzing complex case studies such as " Kevin Sharer at Amgen: Sustaining the High-Growth Company (A) ", ensuring high-quality, academically rigorous solutions.
How do you ensure confidentiality and security in handling client information?
We prioritize confidentiality by using secure data encryption, access controls, and strict privacy policies. Apart from an email, we don't collect any information from the client. So there is almost zero risk of breach at our end. Our financial transactions are done by Paypal on their website so all your information is very secure.
What is Fern Fort Univeristy's process for quality control and proofreading in case study solutions?
The Kevin Sharer at Amgen: Sustaining the High-Growth Company (A) case study solution undergoes a rigorous quality control process, including multiple rounds of proofreading and editing by experts. We ensure that the content is accurate, well-structured, and free from errors before delivery.
Where can I find free case studies solution for Harvard HBR Strategy Case Studies?
At Fern Fort University provides free case studies solutions for a variety of Harvard HBR case studies. The free solutions are written to build "Wikipedia of case studies on internet". Custom solution services are written based on specific requirements. If free solution helps you with your task then feel free to donate a cup of coffee.
I’m looking for Harvard Business Case Studies Solution for Kevin Sharer at Amgen: Sustaining the High-Growth Company (A). Where can I get it?
You can find the case study solution of the HBR case study "Kevin Sharer at Amgen: Sustaining the High-Growth Company (A)" at Fern Fort University.
Can I Buy Case Study Solution for Kevin Sharer at Amgen: Sustaining the High-Growth Company (A) & Seek Case Study Help at Fern Fort University?
Yes, you can order your custom case study solution for the Harvard business case - "Kevin Sharer at Amgen: Sustaining the High-Growth Company (A)" at Fern Fort University. You can get a comprehensive solution tailored to your requirements.
Can I hire someone only to analyze my Kevin Sharer at Amgen: Sustaining the High-Growth Company (A) solution? I have written it, and I want an expert to go through it.
🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Pay an expert to write my HBR study solution for the case study - Kevin Sharer at Amgen: Sustaining the High-Growth Company (A)
Where can I find a case analysis for Harvard Business School or HBR Cases?
You can find the case study solution of the HBR case study "Kevin Sharer at Amgen: Sustaining the High-Growth Company (A)" at Fern Fort University.
Which are some of the all-time best Harvard Review Case Studies?
Some of our all time favorite case studies are -
Can I Pay Someone To Solve My Case Study - "Kevin Sharer at Amgen: Sustaining the High-Growth Company (A)"?
Yes, you can pay experts at Fern Fort University to write a custom case study solution that meets all your professional and academic needs.
Do I have to upload case material for the case study Kevin Sharer at Amgen: Sustaining the High-Growth Company (A) to buy a custom case study solution?
We recommend to upload your case study because Harvard HBR case studies are updated regularly. So for custom solutions it helps to refer to the same document. The uploading of specific case materials for Kevin Sharer at Amgen: Sustaining the High-Growth Company (A) ensures that the custom solution is aligned precisely with your needs. This helps our experts to deliver the most accurate, latest, and relevant solution.
What is a Case Research Method? How can it be applied to the Kevin Sharer at Amgen: Sustaining the High-Growth Company (A) case study?
The Case Research Method involves in-depth analysis of a situation, identifying key issues, and proposing strategic solutions. For "Kevin Sharer at Amgen: Sustaining the High-Growth Company (A)" case study, this method would be applied by examining the case’s context, challenges, and opportunities to provide a robust solution that aligns with academic rigor.
"I’m Seeking Help with Case Studies,” How can Fern Fort University help me with my case study assignments?
Fern Fort University offers comprehensive case study solutions, including writing, analysis, and consulting services. Whether you need help with strategy formulation, problem-solving, or academic compliance, their experts are equipped to assist with your assignments.
Achieve academic excellence with Fern Fort University! 🌟 We offer custom essays, term papers, and Harvard HBR business case studies solutions crafted by top-tier experts. Experience tailored solutions, uncompromised quality, and timely delivery. Elevate your academic performance with our trusted and confidential services. Visit Fern Fort University today! #AcademicSuccess #CustomEssays #MBA #CaseStudies
How do you handle tight deadlines for case study solutions?
We are adept at managing tight deadlines by allocating sufficient resources and prioritizing urgent projects. Our team works efficiently without compromising quality, ensuring that even last-minute requests are delivered on time
What if I need revisions or edits after receiving the case study solution?
We offer free revisions to ensure complete client satisfaction. If any adjustments are needed, our team will work closely with you to refine the solution until it meets your expectations.
How do you ensure that the case study solution is plagiarism-free?
All our case study solutions are crafted from scratch and thoroughly checked using advanced plagiarism detection software. We guarantee 100% originality in every solution delivered
How do you handle references and citations in the case study solutions?
We follow strict academic standards for references and citations, ensuring that all sources are properly credited according to the required citation style (APA, MLA, Chicago, etc.).